Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 53 min ago
Peer-reviewedCC BY-NC-NDJournal of extracellular vesicles

Helicobacter pylori Infection Remodels Neutrophil‐Derived Extracellular Vesicles, Promoting Stress and Apoptosis in Infected Epithelial Cells

  1. 1Indian Institute of Technology Mandi

Abstract

Helicobacter pylori is a Gram‐negative bacterium that establishes colonization in the human stomach and is estimated to infect over half of the global population. It is recognized as a significant causative agent of chronic gastritis, peptic ulcers, and gastric cancer. Neutrophils play a central role in innate defence against H. pylori; however, dysregulated neutrophil activation contributes to epithelial injury and persistent inflammation. Here, we show that H. pylori enhance neutrophil exocytosis and stimulates the release of extracellular vehicles (EVs) with distinct biophysical and molecular characteristics. Infected neutrophils released smaller and more abundant EVs than uninfected controls. These H. pylori–induced neutrophil EVs (HPN‐EVs) suppressed PI3K/Akt signalling, increased reactive oxygen species, disrupted mitochondrial integrity, and induced cytochrome c release, caspase activation, and apoptosis in infected gastric epithelial cells. Proteomics profiling revealed enrichment of neutrophil granule proteins, particularly LL‐3, and depletion of proteins associated with cellular homeostasis. EV‐mediated LL‐37 delivery reproduced key pro‐apoptotic effects of HPN‐EVs, supporting its functional role in epithelial injury. Consistent with these findings, circulating EVs from H. pylori‐infected patients exhibited elevated LL‐37 levels and induced similar pro‐apoptotic responses. Together, these findings identify LL‐37‐enriched HPN‐EVs as important mediators of neutrophil–epithelial crosstalk and investigating EV‐associated cargo as a potential therapeutic target in H. pylori‐associated disease.

Related

  1. The Role of Neutrophil Extracellular Traps (NETosis) in Systemic Lupus Erythematosus: Molecular Mechanisms, Pathogenic Roles, Diagnostic Biomarkers, and Emerging Therapeutic Strategies
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  2. Epithelial-endothelial barrier dysfunction and oxidative stress in ARDS subphenotypes: comparative efficacy of extracellular vesicles derived from bone marrow (MSC-EVs) and adipose tissue (ASC-EVs) mesenchymal stem cells
    A. Burello, G. Tiberi, P. A. D. Villegas +14
    medRxivPreprintAll rights reservedFull textMolecular biology & gene regulationmedRxiv
  3. Hsa_Circ_0000615-Encoded 250-Amino Acid Polypeptide Suppresses Epithelial Ovarian Cancer Progression via Promoting HMGB1 Nuclear Accumulation
    Ziyi Guo, Siyun Deng, Jiao Meng +11
    Oncology ResearchPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  4. A new strategy to count and sort neutrophil‐derived extracellular vesicles: Validation in infectious disorders
    Amandine Bonifay, Stéphane Robert, Belinda Champagne +9
    Journal of Extracellular VesiclesPeer-reviewedCC BY-NC-ND 4.0Full text20 citedMolecular biology & gene regulationHAL
  5. Trophoblast derived extracellular vesicles trigger secondary vesicle release from endometrial epithelial cells.
    Subhashini Muhandiram, Seyed Omid Reza Mousavi, Suranga Kodithuwakku +5
    Cell communication and signaling : CCSPeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationEurope PMCDOAJ
BibTeX
@article{keshri2026helicobacter,
  title = {{Helicobacter pylori Infection Remodels Neutrophil‐Derived Extracellular Vesicles, Promoting Stress and Apoptosis in Infected Epithelial Cells}},
  author = {Anand Kumar Keshri and Suraj Singh Rawat and Durganand Thakur and Swati Sharma and Parul Mehra and Anubha Chaudhary and Ananaya Kapoor and Amit Prasad},
  journal = {Journal of extracellular vesicles},
  year = {2026},
  month = nov,
  doi = {10.1002/jev2.70388},
  url = {https://europepmc.org/article/PMC/PMC13730263},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Helicobacter pylori Infection Remodels Neutrophil‐Derived Extracellular Vesicles, Promoting Stress and Apoptosis in Infected Epithelial Cells
AU  - Anand Kumar Keshri
AU  - Suraj Singh Rawat
AU  - Durganand Thakur
AU  - Swati Sharma
AU  - Parul Mehra
AU  - Anubha Chaudhary
AU  - Ananaya Kapoor
AU  - Amit Prasad
PY  - 2026
DA  - 2026/11/01
JO  - Journal of extracellular vesicles
DO  - 10.1002/jev2.70388
UR  - https://europepmc.org/article/PMC/PMC13730263
AB  - Helicobacter pylori is a Gram‐negative bacterium that establishes colonization in the human stomach and is estimated to infect over half of the global population. It is recognized as a significant causative agent of chronic gastritis, peptic ulcers, and gastric cancer. Neutrophils play a central role in innate defence against H. pylori; however, dysregulated neutrophil activation contributes to epithelial injury and persistent inflammation. Here, we show that H. pylori enhance neutrophil exocytosis and stimulates the release of extracellular vehicles (EVs) with distinct biophysical and molecular characteristics. Infected neutrophils released smaller and more abundant EVs than uninfected controls. These H. pylori–induced neutrophil EVs (HPN‐EVs) suppressed PI3K/Akt signalling, increased reactive oxygen species, disrupted mitochondrial integrity, and induced cytochrome c release, caspase activation, and apoptosis in infected gastric epithelial cells. Proteomics profiling revealed enrichment of neutrophil granule proteins, particularly LL‐3, and depletion of proteins associated with cellular homeostasis. EV‐mediated LL‐37 delivery reproduced key pro‐apoptotic effects of HPN‐EVs, supporting its functional role in epithelial injury. Consistent with these findings, circulating EVs from H. pylori‐infected patients exhibited elevated LL‐37 levels and induced similar pro‐apoptotic responses. Together, these findings identify LL‐37‐enriched HPN‐EVs as important mediators of neutrophil–epithelial crosstalk and investigating EV‐associated cargo as a potential therapeutic target in H. pylori‐associated disease.
SN  - 2001-3078
ER  -